Journal profile · RESPIRATORY SYSTEM
COPD-Journal of Chronic Obstructive Pulmonary Disease
ISSN 1541-2555 · eISSN 1541-2563 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 2004
COPD-Journal of Chronic Obstructive Pulmonary Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.65; JCR Q2 (journal website); fully open access; APC about USD 3,300; median 102 days to acceptance (86 articles, last 24 months); community-reported acceptance: fairly easy; 43 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
COPD-Journal of Chronic Obstructive Pulmonary Disease is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms and Asthma and respiratory diseases, together about 63.8% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
COPD: Journal of Chronic Obstructive Pulmonary Disease publishes a wide range of research to promote advances in the pathophysiology, genetics, diagnosis, pharmacological and non-pharmacological treatments, and rehabilitation of COPD. The journal provides a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care. Types of articles include original research, reviews, commentaries, and conference proceedings. This journal is of interest to: Pulmonary disease specialists Internal medicine, primary care and family practice physicians Intensive care specialists Thoracic surgeons Cardiologists Clinical allergists Physiotherapists Nurses Social workers Psychiatrists and psychologists Please note that COPD converted to a full Open Access journal from Volume 19 (2022). Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Vito BrusascoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine37.6%
- Respiratory Support and MechanismsMedicine15.2%
- Asthma and respiratory diseasesMedicine11%
- Respiratory and Cough-Related ResearchMedicine4.7%
- Cardiovascular and exercise physiologyMedicine2.6%
- Delphi Technique in ResearchSocial Sciences2.5%
- Pediatric health and respiratory diseasesHealth Professions2.3%
- Inhalation and Respiratory Drug DeliveryMedicine2.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest, OCLC, Adis International Ltd., EBSCOhost, VINITI RAN; Referativnyi Zhurnal
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.65LetPub ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 4Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SJR (publisher) 2025
- 0.62Publisher website ·
- SNIP 2026-06
- 0.72LetPub ·
- SNIP (publisher) 2025
- 0.72Publisher website ·
- h-index
- 52LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 962OpenAlex ·
- 2-year mean citedness
- 2.84OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 37LetPub ·
- Downloads per year (publisher)
- 664,000Publisher website ·
Articles by year OpenAlex count · 1,633 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 46 | 46 | 27 |
| 2025 | 43 | 43 | 135 |
| 2024 | 37 | 37 | 196 |
| 2023 | 39 | 39 | 292 |
| 2022 | 37 | 37 | 409 |
| 2021 | 83 | 69 | 1,230 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
102 daysMedian, submission to acceptance · P25–P75 63 days – 129 days
- Acceptance to online
- median 25 days (87 articles)
- Submission to online
- median 126 days
- Sample
- 86 articles with submission and acceptance dates (99 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 17%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 48 daysPublisher website ·
- Acceptance to publication
- 41 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,300 / GBP 2,640 / EUR 3,170 / AUD 4,595 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 / GBP 2,085 / EUR 2,415 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- commentariesTypes of articles include original research, reviews, commentaries, and conference proceedings.Length not stated
- conference proceedingsTypes of articles include original research, reviews, commentaries, and conference proceedings.Length not stated
- original researchTypes of articles include original research, reviews, commentaries, and conference proceedings.Length not stated
- reviewsTypes of articles include original research, reviews, commentaries, and conference proceedings.Length not stated
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Open access journal; only publishes open access articles. Model summary
COPD: Journal of Chronic Obstructive Pulmonary Disease is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and re…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1541-2555
- Electronic ISSN
- 1541-2563
- Latest issue on the website
- Volume 23, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about COPD-Journal of Chronic Obstructive Pulmonary Disease
What CAS zone is COPD-Journal of Chronic Obstructive Pulmonary Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, COPD-Journal of Chronic Obstructive Pulmonary Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of COPD-Journal of Chronic Obstructive Pulmonary Disease?
The latest impact factor listed by LetPub is 2.65; CiteScore 4, h-index 89.
How long does peer review take at COPD-Journal of Chronic Obstructive Pulmonary Disease?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 63–129 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 17%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is COPD-Journal of Chronic Obstructive Pulmonary Disease in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index COPD-Journal of Chronic Obstructive Pulmonary Disease?
According to LetPub and DOAJ records, COPD-Journal of Chronic Obstructive Pulmonary Disease is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is COPD-Journal of Chronic Obstructive Pulmonary Disease open access, and what is the APC?
COPD-Journal of Chronic Obstructive Pulmonary Disease is a fully open-access journal. APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .